Peer Review History

Original SubmissionNovember 2, 2020
Decision Letter - David Mackey, Editor, Wenbo Ma, Editor

Dear Dr Rieux,

Thank you very much for submitting your manuscript "First historical genome of a crop bacterial pathogen from herbarium specimen: insights into citrus canker emergence" for consideration at PLOS Pathogens.

First off, I'd like to apologize for length of time that has passed since this paper was submitted. Difficulty in recruiting reviewers and receiving reviews, compounded by the holiday break, resulted in the delay.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

David Mackey

Associate Editor

PLOS Pathogens

Wenbo Ma

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The manuscript entitled “First historical genome of a crop bacterial pathogen from herbarium specimen: insights into citrus canker emergence” by P.E. Campos and co-authors reports for the first time the description of the genome of a plant bacterial pathogen from a herbarium specimen. The authors targeted a 1937 specimen of Citrus sp. from Mauritius island (located in South West Indian Ocean, SWIO) showing typical symptoms of Asiatic citrus canker, an economically important disease caused by Xanthomonas citri pv. citri (Xci). They first confirmed the historical nature of the reconstructed genome HERB_1937 Xci by characterizing the DNA degradation patterns specific to ancient DNA. The authors further described the associated metagenome and again excluded recent contaminations by looking at the aDNA patterns of the most predominant taxon of the associated bacterial community. They investigated the HERB_1937_Xci gene content both on the chromosome and the two plasmids focusing on virulence factors and revealed a full equipment for virulence and detected three new allele sequence in TALE genes that are important for virulence. Then the authors compared the HERB_1937_Xci genome with a large set of modern genomes, especially including many genomes originating from the SWIO region. They performed a phylogenetic reconstruction which confidently placed HERB_1937_Xci at the root of the modern SWIO strains lineages making him a very likely member of the founder population. Having ensured the presence of a temporal signal, the authors finally estimated evolutionary parameters using a tip-calibration inference/ Bayesian tip-calibration inferences and refined the estimation of the age of the ancestor of modern SWIO strains proposing a scenario for the emergence of ACC in the SWIO region.

The authors have taken the opportunity of an immense resource of biodiversity that lies in the herbaria to increase our present knowledge on genetic diversity of a bacterial plant quarantine pathogen that still threatens large areas of citrus production. They reconstructed the introduction routes of this invasive bacterial species in SWIO. The evolutionary history that can be deduced provides information about the origin and history of the ACC emergence and the construction of the genetic diversity of the SWIO Xci populations.

They have produced original and new results that underline the interest of the methodological approach. From what I can judge, this methodological approach and the analyses implemented are appropriate and relevant to reach the conclusions presented. The manuscript is well written and the results are clearly presented.

Reviewer #2: Strength

First study to sequence the whole bacterial genome of an important plant pathogen in a historic herbarium sample

Data analysis was thorough and paper is well- written

Weakness

Could have sequenced more specimens to address migration and root tree and examine evolution for genome over time.

Did not justify why they chose this particular sample.

Reviewer #3: This manuscript makes another contribution to a relatively underexplored area in ancient DNA – herbarium specimens from historical collections that show indications of infection. I was asked to comment specifically on the measures of authenticity regarding ancient DNA acquisition and analysis, so my comments largely relate to that. These comments aside, the paper is very clearly written and the analyses are extensive. I include a few comments below that might improve quality of the analysis.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: No major issues to be discussed here.

Reviewer #2: Need to sequence more historic genomes to justify some of their conclusions. That would make the paper stronger. They included a lot of previously sequenced genome data from modern lineages. For this work, I would ask them to qualify their conclusions and not do additional experiments

Reviewer #3: First, it is typical in ancient DNA studies to eliminate all reads 30bp and shorter, after trimming (if this is done, which it is here). It seems the authors have not done so, despite their caution against it (line 172).

The damage plot they present in Figure 4b is also confusing. The use of two horizontal axes, one on the top and one on the bottom, is confusing, as they are clearly independent, though at first glance they look as though they are describing the damage profiles of all reads 25bp in length. A more intuitive way to show their damage profiles would be to show the 5’and 3’ plots side by side. They could show only the first 25bp of the read in either direction, but this removes the ambiguity of the relationship between the positions in the 5’ and 3’ ends as shown in the current plot.

Line specific comments:

Line 61: Change “fossil remains” to “preserved tissues” or something similar, as fossils are rock with no preserved biological tissues

Line 105 – a sentence or two describing the preservation conditions of the sample would be helpful

Line 109 – it’s not clear if the reads were merged, or simply treated as regular mate pair data. Reads should be merged, as treatment as modern paired end data would lead to incorrect base calling due to high background DNA. Treatment of each read independently will result in SNP calls in duplicate reads (via a call in both the forward and reverse read) and will inflate SNP coverage, which could be an issue with high non-target background. I suggest they merge their reads and reprocess the data.

Line 116 – Greater clarity is needed here to explore how these percentages were generated. I assume via BLAST? What seems to be missing is a description of the percent Xci DNA in bulk DNA content based on mapping to a reference. This is a key value in aDNA studies.

Line 127 – Remove or edit the passage “as compared to the standard read length of 150 nt obtained for modern Xci samples”, since read length is dependent on the sequencing platform and kit, and that is not clear based on this description.

Line 144 – 148: I’m not sure why the authors opted to make this comparison. A far more informative metric would be to compare the Xci DNA damage profile to that of the host (perhaps to a plastid or a chromosome). That is typically done as a means of authenticity in ancient pathogen investigations.

Table 1: Column 2 should be % of reads mapping to the reference based on total DNA content (% endogenous DNA), before duplicate removal. Currently this represents the proportion of mapped reads that assigns to the genetic component, which isn’t as informative. Column 3 is called “Mean depth”, though I suppose they mean “Mean coverage”, which is a clearer term. Last column, which shows the % reads with damaged terminal bases show values between 1.62 and 1.88, though 2.64% is reported in the main text (line 135). Why the discrepancy?

Lines 168 – 169: Reporting % of the reference covered at 1X is not terribly informative, especially if base calling required a min of 15-fold coverage (as is described in the methods). Also is it not clear if the map quality was 0 or higher. If it was 0, the authors are reporting reads that will map to multiple locations in the genome, which could inflate their coverage, especially if these positions are later removed for SNP calling.

Line 273 – “obtained from such material”… greater specificity is needed here to describe what “such material” is.

Line 277 – “contamination-free environment”: no environment is contamination-free.

Lines 291 – 293: There is no need to explore the reasons for 60% of the reads not mapping to a reference. This is a nearly ubiquitous phenomenon in ancient DNA work, and probably also in modern metagenomics studies.

Line 295 – change “studies” to “study”

Line 297 – were the preservation conditions for P. infestans similar?

Line 298 – “in the reads mapping to either of two plasmids” is a better way to say this

Lines 331 – 334: If a conclusion is being drawn from tree topology, the ML tree with bootstraps should ideally be included in the main text. Currently the authors include only the Bayesian tree, which was constructed with the ML tree as a prior (if I have understood the methods properly)

Line 361 – typo “deshydrogenase”

Lines 392 – 403: There is some odd grammar in this concluding paragraph, and the English should be adjusted for better clarity

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: Minor comments are indicated below

The first three points are free comments and do not necessarily need to be followed up on.

- Line 45. And to possibly close the loop, loss of biodiversity can impact disease risk (Keesing, 2006, Ecol. Lett. 9:485; Rohr et al., 2020, Nature Ecol. & Evol. 4:24).

- May be you could refer to the pioneering work of Ristaino et al (2001, Nature 411:695).

- Line 91. You could add a sentence highlighting further the contribution of herbarium specimens in deciphering the original outbreak of ACC in Florida at the beginning of the twentieth century (Li et al., 2007).

- Line 105 (and line 416). DNA was extracted from a pool of five lesions which could represent independent infection events. Is there any possibility of strains mixture? Or did you observe any sequence variation within HERB_1937_Xci that could be attributed to the presence of different strains?

- Line 115. You talk about identified sequences at the species level but the taxonomic level of the plant host is at the genus level. Even if this was not your objective, did you get any clues from the reads about the species identification of your citrus specimen?

- Line 199. Change to S3 Table for homogenization.

- Line 261. Check with Fig 6b where R2 = 0.043 and p-value = 0.0105.

- Line 312. Did you estimate any genetic diversity indices to support this assertion?

- Line 336. Can a privileged ancient history between these two islands explain older migration events and shed light on the presence of older Xci common ancestors?

Bibliography

- Line 645. Change to canker-like.

- Line 743. Reference Bolger et al. to be completed.

- Line 776. Prefer: Jombart T., Balloux F., Dray S., adephylo: new tools for investigating the phylogenetic signal in biological traits, Bioinformatics, Volume 26, Issue 15, 1 August 2010, Pages 1907–1909, https://doi.org/10.1093/bioinformatics/btq292

I could not consult the data associated with HERB_1937 deposited to the SRA and on GenBank database which were not yet available.

Reviewer #2: Page Line Comments

Abstract 1 Change to “ancient genomics has been used”

3 43 Add a . after (3) and start new sentence with “More”

3 46 Change to “infectious crop” diseases

3 54 Rework this sentence as there have been studies with herbarium collections that sampled over more than 4 decades. See paper by Ristaino et al “Ristaino, J. B. 2020. The importance of mycological and plant herbaria in tracking a plant killer. Front. Ecol. Evol. 7:521. doi: 10.3389/fevo.2019.00521” for a review of the studies with plant mycological collections to track plant disease epidemic”.

3 58 Delete “to” and change to “systemic detection of evolutionary changes or reconstruction of …”

4 63 Add more citations here. Yoshida was not the first to use herbarium specimens to identify the famine-era lineage of P. infestans. Cite “May, K. J. and Ristaino, J. B. 2004. Identity of the Mitochondrial DNA Haplotype(s) of Phytophthora infestans in Historical Specimens from the Irish Potato Famine. Mycol. Res. 108:171-179.”

4 81 Add more citations here “Saville, A. , Martin, M, Gilbert, T. and Ristaino, J. 2016. Historic late blight outbreaks caused by a widespread dominant lineage of Phytophthora infestans (Mont.) de Bary Plos One 11: e0168381 https://doi.org/10.1371/journal.pone.0168381” and others mentioned previously. I’d like to think our work has helped resolved the debate about the identity and source of the 19th century outbreak.

5 84 Cite Li et al. (26) here as Hartungs work did use herbarum specimens to study citrus canker and I believe did the first genetic work with a historic strain from 1911. Although they did not use full genomes sequences they did to multilocus genotyping so say a bit more here and compare your results to previous work in the discussion.

5 104 Indicate the name of the herbarium that the sample was retrieved from and define SWIO.

6 116 There was a greater percentage of reads from some other bacterial species than X. citir (1.2% vis Methylbacterium 1.57%) Methylobacterium has been identified as a contaminant during DNA extraction and can lead to its erroneous appearance in microbiota or metagenomic datasets. Did you run a preliminary PCR on the samples to confirm they were actually infected with X citri before the llumina sequencing using species specific primers. Rep or Box PCR, etc It would be good to conform or look for sequences specific to the pathogen to confirm that the samples were infected by X citri.

6 122 Could reduce some of this section about DNA damage as its clear you are using herbarium material and the read will likely be short.

9 175 Did you sequence more than one herbarium sample? Why was this particular sample of interest. Is the oldest existing specimen? It would have been better to sequence more samples from the various islands and at different times in the past to present day.

10 199 The data on the T3SS is interesting. Were the absent genes viewed necessary for virulence in modern lineages?

10 215 This mapping method that uncovered new reads in the TALE region is interesting

11 227 Say more about the number and location of the SNPS. What do you mean by “dubious SNPS”?

12 268 I can’t help but think that sequencing more samples would also have improved the root date of the tree. What do you know about movement of citrus during this time period? Are there historical records on the introduction of the pathogen that might indicate times of introduction?

13 274 Add more citations here as stated above on page 3 line 54.

13 284 Sequencing more samples would have given you an indication of whether this was contamination or infection by other bacteria.

14 320 Are the French botanists samples available in the Paris herbarium? These would be interesting to see if you can push back the introduction date.

15 331 You really need more samples to determine if one or more introduction occurred or even it the same pathovar was introduced. This is speculation so reword this.

15 333 You could do migration analysis on the data to see if directional gene flow has occurred among the island nations.

16 363 How would this influence pathogenicity – more or less pathogenic? Is the historic lineage potentially more virulent then modern day lineages or not?

17 374 I encourage you to continue more sequencing of historic genomes of this important pathogen so you can try de novo genome assembly and do further migration and phylogenetic analysis . Search for specimens in unlikely places. They may be in museum collections from explorers to the region including the British.

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plospathogens/s/submission-guidelines#loc-materials-and-methods

Revision 1

Attachments
Attachment
Submitted filename: Answer_to_reviewers.docx
Decision Letter - David Mackey, Editor, Wenbo Ma, Editor

Dear Dr Rieux,

Thank you very much for submitting your manuscript "First historical genome of a crop bacterial pathogen from herbarium specimen: insights into citrus canker emergence" for consideration at PLOS Pathogens. This revised version of your manuscript was reviewed by one of the previous independent reviewers. They make several suggestions to further improve the manuscript. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please take special care to address the concern regarding in-lab contamination and the need to report on mapping reads in the negative control.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

David Mackey

Associate Editor

PLOS Pathogens

Wenbo Ma

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #3: (No Response)

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #3: (No Response)

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #3: I appreciate that the authors took the time to reprocess their data as merged, as this did have an effect on their coverage estimates. I’m slightly curious as to why the merged data resulted in a greater number of genomic regions with no coverage, as I would have thought that merging would result in a reduction of reads spanning only those positions that were covered via paired end analysis. Was the map quality metric altered between these two analyses? Certainly increasing the map quality could lead to this phenomenon. Typically map quality values of 30 or even 37 are used, not just removal of reads with map quality 0. Regarding coverage thresholds for SNP calling, the authors have now used average depth as a criterion for inclusion in the analysis, citing a study (ref 1 of their response) as a demonstration of this approach. While this approach is acceptable in their case, it should not be considered a global criterion for ancient DNA work, where coverage is often highly variable and can be very low. It is customary to set a threshold independent of coverage such as 3X or better yet 5X for SNP calling with ancient data.

I thank the authors for including their percent Xci DNA in bulk content (0.74%). I have not seen them disclose their sequencing depth anywhere in the manuscript, and that should be mentioned ideally in the main text. Their genomic reconstruction was performed from 1.6 million mapping reads, so by extension I assume their sequencing depth was ca. 220 million reads. I’m also curious about why the BLAST analysis assigned 1.2% of bulk DNA to Xci. I would have thought BLASTn would have returned fewer reads assigned to Xci compared to mapping, since the mapping process is based on read similarity only. Was a filtering step applied before the mapping? A comment about this difference could be useful.

A description of the mapping process and statistics of the Xci mapping should be presented in the main text before the damage assessment, which is calculated based on the mapped reads. They should also be clear on line 146 that their patterns of degradation apply to reads mapping to the Xci reference genome as opposed to simply “degradation in HERB_1937” as is it currently stated. Why are the damage profiles now shown in both the main manuscript (for the chromosome) and the SI (for the chromosome and two plasmids)? Why not just show the current SI image in the main text? I also caution the authors against making assumptions that damage alone will “itself prove the authenticity” (wording from response letter) of their data. If they were to evaluate the human reads and observe a similar damage pattern, the data would have to be explained by contamination. Authenticity is conferred through damage profile along with context of the finding. Branch shortening in the phylogeny can be a useful metric for authentication of ancient data, and this is shown in their supplementary ML tree. The authors may wish to mention that as well at some point in the MS to bolster their claim of authenticity, along with highlighting its ancestral phylogenetic position (currently on line 329 outside the context of authenticity). They entertain the possibility on lines 303 – 304 of their data coming from in-lab contamination, but I don’t think this statement is needed in light of the accompanying authenticity data they present. Reporting on the mapping reads in their negative controls is currently missing in the main manuscript and absolutely must be included: This should also help to rule out in-lab contamination.

The resolution of the main text images I received is of poor quality, and it looks like the samples have 20% damage as opposed to 2% damage, which really shocked and confused me at first. Please make sure that high resolution figures accompany the manuscript in print.

In their table 1 (main MS), I assume “most extreme position” refers to the terminal position? I’ve not come across that terminology and I find it unintuitive. Also, it is not common for % damaged bases to be presented as an average over the terminal five nucleotides, as the authors have done here. % damage at the terminal 5’ and 3’ ends is sufficient and is more commonly reported.

Is it worth mention that the reads mapping to Xci are shorter than average for bulk DNA content and those mapping to Methylobacterium are longer than average? Do the authors know of a biological reason for this difference? GC content perhaps? Cellular structure?

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Revision 2

Attachments
Attachment
Submitted filename: Answer to reviewer.pdf
Decision Letter - David Mackey, Editor, Wenbo Ma, Editor

Dear Dr Rieux,

We are pleased to inform you that your manuscript 'First historical genome of a crop bacterial pathogen from herbarium specimen: insights into citrus canker emergence' has been provisionally accepted for publication in PLOS Pathogens. The careful and thorough responses to review comments was much appreciated.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

David Mackey

Associate Editor

PLOS Pathogens

Wenbo Ma

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Formally Accepted
Acceptance Letter - David Mackey, Editor, Wenbo Ma, Editor

Dear Dr Rieux,

We are delighted to inform you that your manuscript, "First historical genome of a crop bacterial pathogen from herbarium specimen: insights into citrus canker emergence," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .